Mapping the human genome for chronic itch holds the potential to develop targeted therapy for atopic dermatitis and psoriasis itch, a study shows.
The Food and Drug Administration is in the process of evaluating scientific data on the safety of probiotics and postbiotics in cosmetics, said Linda Katz, M.D., director of the Office of Cosmetics and Color for the FDA.
Perry Robins, M.D., has launched a training program designed for RNs, NPs and PAs and other healthare professionals interested in pursuing a dermatology-focused education in skin, health and anti-aging.
A Johns Hopkins study finds that physicians who use stigmatizing language in their patients' medical records, may actually be hurting the care those patients get for years to come.
In June, the European Commission approved tofacitinib citrate (Xeljanz/Pfizer) 5 mg twice daily in combination with methotrexate for adults with psoriatic arthritis. Learn about the parameters here.
Hawaii has the most overworked RN workforce, according to a report by Medicare Health Plann issued in June.
In June, Dermira Inc. announced the FDA approval of Qbrexza (glycopyrronium) for primary axillary hyperhidrosis ― excessive underarm sweating.
While patient-centered medicine works well for patients, what does it mean for the practice?
The U.S. landscape of neuromodulators, which play well with other aesthetic treatments, continues to expand, said experts at The Cosmetic Bootcamp.
Two months ago in Hong Kong, a 23-year-old woman was reportedly so tormented by chronic eczema that she killed her parents, then herself in an act that brought attention to the stress of living with a life-long skin condition.